Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Stem Cell Transplant for Metastatic Renal Cell Carcinoma
NCT00027573Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Oct 2001
- Primary completion
- Jun 2006
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic allogeneic lymphocytes in renal cell carcinoma (RCC), sponsored by Cancer and Leukemia Group B. Started Oct 2001; status: completed.
02
Drugs
therapeutic allogeneic lymphocytes
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00027573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027573.